Table 1.
I1–40 | |||
compound | R1 | R |
AtHPPD inhibition Ki (μM) |
I1 | H | 1.5 ± 0.031 | |
I2 | H | 1.3 ± 0.017 | |
I3 | 2-chloro | 0.36 ± 0.012 | |
I4 | 2-chloro | 0.59 ± 0.043 | |
I5 | 4-chloro | 1.0 ± 0.036 | |
I6 | 4-chloro | 0.93 ± 0.032 | |
I7 | 2,4-dichloro | 0.36 ± 0.012 | |
I8 | 2,4-dichloro | 0.22 ± 0.023 | |
I9 | 2,4,6-trichloro | 0.31 ± 0.048 | |
I10 | 2,4,6-trichloro | 0.24 ± 0.003 | |
I11 | 2,4,6-trichloro | 0.081 ± 0.001 | |
I12 | 2,4,6-trichloro | 0.011 ± 0.012 | |
I13 | 2-nitro | 0.45 ± 0.033 | |
I14 | 2-nitro | 0.21 ± 0.042 | |
I15 | 2-nitro | 0.27 ± 0.004 | |
I16 | 2-nitro | 0.44 ± 0.013 | |
I17 | 4-nitro | 0.23 ± 0.004 | |
I18 | 4-nitro | 0.93 ± 0.006 | |
I19 | 4-nitro | 0.63 ± 0.002 | |
I20 | 4-nitro | 0.50 ± 0.003 | |
I21 | 4-nitro | 1.5 ± 0.041 | |
I22 | 2-chloro-4-nitro | 1.02 ± 0.009 | |
I23 | 2-chloro-4-nitro | 0.012 ± 0.009 | |
I24 | 2-chloro-4-nitro | 0.26 ± 0.012 | |
I25 | 2-chloro-4-nitro | 0.21 ± 0.043 | |
I26 | 2-(2,4-dichlorophenoxy)-4-chloro | 1.9 ± 0.001 | |
I27 | 2-(2,4-dichlorophenoxy)-4-chloro | 2.2 ± 0.041 | |
I28 | 2-(2,4-dichlorophenoxy)-4-chloro | 0.032 ± 0.002 | |
I29 | 2-(2,4-dichlorophenoxy)-4-chloro | 1.3 ± 0.022 | |
I30 | 2,4-dimethyl | 2.2 ± 0.034 | |
I31 | 2,4-dimethyl | 3.1 ± 0.34 | |
I32 | 2,4-dmethyl | 2.0 ± 0.009 | |
I33 | 2,4-dimethyl | 2.8 ± 0.045 | |
I34 | 2,4-dimethyl | 2.8 ± 0.67 | |
I35 | 4-methyl-5-methoxy | 3.3 ± 0.14 | |
I36 | 4-methyl-5-methoxy | 3.4 ± 0.21 | |
I37 | 4-methyl-5-methoxy | 2.7 ± 0.53 | |
I38 | 4-methyl-5-methoxy | 2.9 ± 0.038 | |
I39 | H | 1.3 ± 0.056 | |
I40 | H | 1.2 ± 0.031 | |
mesotrione | 0.013 ± 0.001 |